Search Results 1911-1920 of 19630 for Hemoglobin

  1. A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology (Veri-T-001) - Mayo Clinic

    Hemoglobin A1C > 7.5% at screening (confirmed by repeat);. Current or recent history (within four weeks prior to initial screening visit) of a clinically ...

  2. A Global, Randomized, Placebo-controlled Phase 3 Study of Fruquintinib in Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Hemoglobin < 9.0 g/dL. Blood transfusion within 1 week prior to enrollment for the purpose of increasing the likelihood of eligibility is not allowed. Serum ...

  3. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN OR direct bilirubin ...

  4. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  6. Publications - Amy C. Clayton, M.D. - Mayo Clinic

    A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol. 2002 May ...

  7. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery - Mayo Clinic

    Hemoglobin >= 8 g/dL for patients =< 16 years of age; >= 9 g/dL for patients > 16 years of age; Note: no transfusions are permitted 7 days prior to ...

  8. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

    Hemoglobin ≥ 8 g/dL. Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum ...

  9. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Hemoglobin (HgB) > 9 g/dL. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment. Patient has the following blood ...

  10. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    * Hemoglobin level ≤ 9.0 g/dL * Absolute neutrophil count ≤ 1.7 × 109 for subjects who will receive cabazitaxel; \< 1.0 × 109/L for all others * Aspartate ...